IE 11 is not supported. For an optimal experience visit our site on another browser.

Immucor Announces Senior Management Change

NORCROSS, Ga., April 14, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Geoffrey S. Crouse has resigned as Chief Operating Officer, effective immediately.
/ Source: GlobeNewswire

NORCROSS, Ga., April 14, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Geoffrey S. Crouse has resigned as Chief Operating Officer, effective immediately.

"We would like to thank Geoff for his contribution and wish him the best in his future endeavors," stated Dr. Gioacchino De Chirico, Immucor's President and Chief Executive Officer.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.

CONTACT: Michele Howard 770-441-2051